Monday, 20. August 2012
The question is a federal infrastructure that will give a seal of approval on what to do, he said. He urged doctors and patients to have deep mistrust in the search mode may be used as Washington tries to find a way to save hundreds of billions of dollars as part of health reform in general.Most patients do not talk about the price when getting a prescription from their doctor of medicine, and compare their real prices before it is time to pay at the pharmacy, according to a survey published by Consumers Union.
Robert Moffitt, director of the Center for Policy Studies at the Heritage Health Foundation, said that some are opposed to improved treatments for the best price. Who the hell is against this? He said.
The government has a real opportunity to provide neutral, credible, transparent information to the public for all to see, said Father.
But comparative effectiveness research – or at least the way the government and insurers may use it – is controversial.
The latest issue of the magazine has published a guide to 20 generic classes of drugs, including drugs, and high. Effectiveness comparative research
As the world held its breath Wednesday, transfixed by the rescue of 33 Chilean miners who were trapped underground for 69 days, early indications are that the men had survived their ordeal in surprisingly good health.
If cost is a problem, have a heart to heart with your doctor and make sure he or she knows that the costs are a problem, says John S., MD, internist and director of the Center for the Evaluation of Consumer Reports health.
Consumers Union has published a survey of 2,000 adults showed that only 4 percent of discussion to get a prescription from your doctor about medications up to 60 percent of respondents learned about the price of their drugs in a pharmacy registered the first time .
Shock is really taking a toll on American consumers, says Ed Farrell, director of research at the Consumer Reports National.
Senator Tom Coburn, R-Okla., Also criticized the proposal. They will look at the cost, as England did, and say, we can not afford it and we will not do, he said.
Consumers Union supports Obama’s plan to stimulate research directly comparing the effectiveness of various drugs, devices and other treatments. The hope is to find cheaper treatments or tests that work as well as the more expensive versions.
Pharmaceutical companies, device manufacturers and other industry groups are concerned that this could be used as an excuse to ration health care.
They warn that the government and insurers may decide to pay only for the economic weakening physicians and patients can make decisions.